CISEN: SSY GROUP completed the reduction of 4.52 million shares, with its shareholding decreasing to 5.11%

CISEN announced that its shareholder, Shijiazhuang Four Pharmaceutical Co., Ltd., which holds more than 5% of the shares, has completed its reduction plan. Before this reduction, Shijiazhuang Four Pharmaceutical held 27,661,441 unrestricted tradable shares, accounting for 6.11% of the total share capital. On August 30, 2025, it disclosed the reduction plan, intending to reduce no more than 4,527,000 shares through centralized bidding. As of September 24, Shijiazhuang Four Pharmaceutical had cumulatively reduced 4,520,000 shares, accounting for 0.998% of the total share capital, with a reduction price range of 19.70 - 21.17 yuan/share, totaling 91,220,564 yuan. After the reduction, Shijiazhuang Four Pharmaceutical's holdings decreased to 23,141,441 shares, with a holding ratio of 5.11%. This reduction is consistent with the plan and has not been terminated early